These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29241072)

  • 1. Combined efficacy of oseltamivir, isoprinosine and ellagic acid in influenza A(H3N2)-infected mice.
    Pavlova EL; Simeonova LS; Gegova GA
    Biomed Pharmacother; 2018 Feb; 98():29-35. PubMed ID: 29241072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic and therapeutic combination effects of rimantadine and oseltamivir against influenza virus A (H3N2) infection in mice.
    Simeonova L; Gegova G; Galabov AS
    Antiviral Res; 2012 Aug; 95(2):172-81. PubMed ID: 22617756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study on the antioxidant capacities of synthetic influenza inhibitors and ellagic acid in model systems.
    Pavlova EL; Zografov NN; Simeonova LS
    Biomed Pharmacother; 2016 Oct; 83():755-762. PubMed ID: 27479194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rimantadine and oseltamivir demonstrate synergistic combination effect in an experimental infection with type A (H3N2) influenza virus in mice.
    Galabov AS; Simeonova L; Gegova G
    Antivir Chem Chemother; 2006; 17(5):251-8. PubMed ID: 17176629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination activity of neuraminidase inhibitor oseltamivir and α-tocopherol in influenza virus A (H3N2) infection in mice.
    Galabov AS; Mileva M; Simeonova L; Gegova G
    Antivir Chem Chemother; 2015 Aug; 24(3-4):83-91. PubMed ID: 27341844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oseltamivir and S-Adenosyl-L-Methionine Combination as Effective Therapeutic Strategy for Suppression of Oxidative Damage in Lung Caused by Influenza Virus Infection in Mice.
    Mileva M; Dimitrova A; Krastev D; Alexandrova A; Tsvetanova E; Georgieva A; Galabov A
    Drug Res (Stuttg); 2020 Jun; 70(6):273-279. PubMed ID: 32316058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combinations of 1,8-cineol and oseltamivir for the treatment of influenza virus A (H3N2) infection in mice.
    Lai YN; Li Y; Fu LC; Zhao F; Liu N; Zhang FX; Xu PP
    J Med Virol; 2017 Jul; 89(7):1158-1167. PubMed ID: 27966790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral activity of SA-2 against influenza A virus in vitro/vivo and its inhibition of RNA polymerase.
    Yu J; Wang D; Jin J; Xu J; Li M; Wang H; Dou J; Zhou C
    Antiviral Res; 2016 Mar; 127():68-78. PubMed ID: 26802558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activities of JNJ63623872 and oseltamivir against influenza A H1N1pdm and H3N2 virus infections in mice.
    Smee DF; Barnard DL; Jones SM
    Antiviral Res; 2016 Dec; 136():45-50. PubMed ID: 27771390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oseltamivir-zanamivir combination therapy is not superior to zanamivir monotherapy in mice infected with influenza A(H3N2) and A(H1N1)pdm09 viruses.
    Pizzorno A; Abed Y; Rhéaume C; Boivin G
    Antiviral Res; 2014 May; 105():54-8. PubMed ID: 24583158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germacrone inhibits early stages of influenza virus infection.
    Liao Q; Qian Z; Liu R; An L; Chen X
    Antiviral Res; 2013 Dec; 100(3):578-88. PubMed ID: 24095670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of ergoferon against lethal influenza A (H3N2) virus infection in mice.
    Skarnovich MA; Emelyanova AG; Petrova NV; Borshcheva AA; Gorbunov EA; Mazurkov OY; Skarnovich MO; Tarasov SA; Shishkina LN; Epstein OI
    Antivir Ther; 2017; 22(4):345-351. PubMed ID: 27924780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral activity of novel oseltamivir derivatives against some influenza virus strains.
    Kocik J; Kołodziej M; Joniec J; Kwiatek M; Bartoszcze M
    Acta Biochim Pol; 2014; 61(3):509-13. PubMed ID: 25210935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pharmacologically immunosuppressed mouse model for assessing influenza B virus pathogenicity and oseltamivir treatment.
    Marathe BM; Mostafa HH; Vogel P; Pascua PNQ; Jones JC; Russell CJ; Webby RJ; Govorkova EA
    Antiviral Res; 2017 Dec; 148():20-31. PubMed ID: 29100887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolic mofetil, an alternative antiviral and immunomodulator for the highly pathogenic avian influenza H5N1 virus infection.
    Cho J; Yi H; Jang EY; Lee MS; Lee JY; Kang C; Lee CH; Kim K
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):298-304. PubMed ID: 29017920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of influenza virus-caused oxidative stress by Kegan Liyan oral prescription, as monitored by ascorbyl radical ESR signals.
    Duan S; Gu L; Wang Y; Zheng R; Lu J; Yin J; Guli L; Ball M
    Am J Chin Med; 2009; 37(6):1167-77. PubMed ID: 19938224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ellagic acid on cyclosporine A-induced oxidative damage in the liver of rats.
    Pari L; Sivasankari R
    Fundam Clin Pharmacol; 2008 Aug; 22(4):395-401. PubMed ID: 18705750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects and mechanism of Qingke Pingchuan granules against influenza virus infection.
    He L; Cao J; Xie X; Zhang Y; Zhang X; Wang H; Ma L
    Arch Virol; 2024 May; 169(6):130. PubMed ID: 38807015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination effects of peramivir and favipiravir against oseltamivir-resistant 2009 pandemic influenza A(H1N1) infection in mice.
    Park S; Kim JI; Lee I; Lee S; Hwang MW; Bae JY; Heo J; Kim D; Jang SI; Kim H; Cheong HJ; Song JW; Song KJ; Baek LJ; Park MS
    PLoS One; 2014; 9(7):e101325. PubMed ID: 24992479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral activity of baicalin against influenza A (H1N1/H3N2) virus in cell culture and in mice and its inhibition of neuraminidase.
    Ding Y; Dou J; Teng Z; Yu J; Wang T; Lu N; Wang H; Zhou C
    Arch Virol; 2014 Dec; 159(12):3269-78. PubMed ID: 25078390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.